| SC 13G/A | 2024-05-08 | BlackRock Inc. | Citius Pharmaceuticals, Inc. | 8,625,839 | 4.8% | EDGAR |
| SC 13G | 2024-01-31 | BlackRock Inc. | Citius Pharmaceuticals, Inc. | 8,457,814 | 5.3% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | Citius Pharmaceuticals, Inc. | 2,347,292 | 1.6% | EDGAR |
| SC 13D/A | 2022-02-18 | HOLUBIAK MYRON Z | Citius Pharmaceuticals, Inc. | 3,864,604 | 2.6% | EDGAR |
| SC 13D/A | 2022-02-18 | Mazur Leonard L | Citius Pharmaceuticals, Inc. | 18,092,136 | 11.8% | EDGAR |
| SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | Citius Pharmaceuticals, Inc. | 2,425,000 | 1.6% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Citius Pharmaceuticals, Inc. | 8,128,256 | 5.6% | EDGAR |
| SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | Citius Pharmaceuticals, Inc. | 6,168,361 | 10.0% | EDGAR |
| SC 13G/A | 2020-02-14 | ARMISTICE CAPITAL, LLC | Citius Pharmaceuticals, Inc. | 3,210,927 | 10.0% | EDGAR |
| SC 13G/A | 2020-02-06 | DRILL CRAIG A | Citius Pharmaceuticals, Inc. | 693,600 | 2.4% | EDGAR |
| SC 13G | 2019-05-28 | DRILL CRAIG A | Citius Pharmaceuticals, Inc. | 1,554,500 | 7.0% | EDGAR |
| SC 13G/A | 2019-02-14 | ARMISTICE CAPITAL, LLC | Citius Pharmaceuticals, Inc. | 1,893,490 | 10.0% | EDGAR |
| SC 13G/A | 2019-01-30 | DRILL CRAIG A | Citius Pharmaceuticals, Inc. | 800,000 | 4.5% | EDGAR |
| SC 13G/A | 2019-01-04 | SABBY MANAGEMENT, LLC | Citius Pharmaceuticals, Inc. | 636,698 | 3.6% | EDGAR |
| SC 13D | 2018-08-27 | HOLUBIAK MYRON Z | Citius Pharmaceuticals, Inc. | 2,149,236 | 12.6% | EDGAR |
| SC 13D | 2018-08-27 | Mazur Leonard L | Citius Pharmaceuticals, Inc. | 11,074,173 | 54.2% | EDGAR |
| SC 13G | 2018-08-20 | ARMISTICE CAPITAL, LLC | Citius Pharmaceuticals, Inc. | 1,703,912 | 10.0% | EDGAR |
| SC 13G | 2018-03-29 | SABBY MANAGEMENT, LLC | Citius Pharmaceuticals, Inc. | 648,728 | 6.1% | EDGAR |
| SC 13G | 2018-01-26 | DRILL CRAIG A | Citius Pharmaceuticals, Inc. | 751,018 | 8.7% | EDGAR |